Catheter Precision Inc (AMEX:VTAK) does about 2.12M shares in volume on a normal day but saw 97867512 shares change hands in the recent trading day. The company now has a market cap of 2.85M USD. Its current market price is $0.23, marking an increase of 0.80% compared to the previous close of $0.22. The 52 week high reached by this stock is $8.40 whilst the lowest price level in 52 weeks is $0.16.
The consensus objective for the share price is $2.00, suggesting that the stock has a potential upside of 88.5% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on August 13, 2019 when Piper Jaffray downgraded the stock to “Neutral” and issued a price target of between $9 and $1.50.
The current price level is -4.13%, -18.10%, and -47.57% away from its SMA20, SMA50, and SMA200 respectively, with the VTAK price moving above the 50-day SMA on current market day. Catheter Precision Inc (VTAK) stock is up 15.39% over the week and -20.84% over the past month. Its price is -49.80% year-to-date and -95.81% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
To reach the target analysts have set, the stock logically needs to grow 88.5 percent from here.
Outstanding shares total 11.02M with insiders holding 6.40% of the shares and institutional holders owning 4.67% of the company’s common stock. The company has a return on investment of -126.65% and return on equity of -136.26%. The beta has a value of -0.84. Price to book ratio is 0.27 and price to sales ratio is 5.94.
